Risk of colorectal cancer in patients with primary sclerosing cholangitis and concomitant inflammatory bowel disease compared with primary sclerosing cholangitis only

Documenti analoghi

• Role of PAR1 −506 deletion/insertion polymorphism in primary sclerosing cholangitis
  di: Bettina Langhans, et al.
  Pubblicazione: (2024)
• Validation of PBC‐10 in Japanese patients with primary biliary cholangitis
  di: Akihito Takeuchi, et al.
  Pubblicazione: (2025)
• Fibrosis stage is an independent predictor of liver‐related complications in primary biliary cholangitis
  di: Yukihisa Fujinaga, et al.
  Pubblicazione: (2025)
• Endoscopic management of primary sclerosing cholangitis
  di: Suguru Mizuno, et al.
  Pubblicazione: (2025)
• Anti‐Ro52/TRIM21 autoantibodies predict Sjögren's syndrome in patients with primary biliary cholangitis
  di: Marie Louise Næstholt Dahl, et al.
  Pubblicazione: (2025)